Wordt geladen...
The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
PURPOSE: Enzyme replacement therapy with rhGAA (Myozyme(®)) has lead to improved survival, which is largely attributable to improvements in cardiomyopathy and skeletal muscle function. However, crossreactive immunologic material-negative patients have a poor clinical response to enzyme replacement t...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3954622/ https://ncbi.nlm.nih.gov/pubmed/21637107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GIM.0b013e3182174703 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|